Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine

1Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY;

2Department of Anesthesiology, University of Washington School of Medicine, Seattle, WA;

3Centre for Eudaimonia and Human Flourishing, University of Oxford, Oxford, United Kingdom;

4Department of Psychiatry, University of Oxford, Oxford, United Kingdom;

5University of Nevada, Reno School of Medicine, Reno, NV;

6Department of Neurology, Carson Tahoe Health, Carson City, NV;

7University of Southern California, Keck School of Medicine, Los Angeles, CA;

8Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA;

9Teachers College, Columbia University, New York, NY;

10Fermata Health, Brooklyn, NY; and

11Acacia Clinics, Sunnyvale, CA.

*Address for correspondence: Kenneth Shinozuka, BA, Centre for Eudaimonia and Human Flourishing, 7 Stoke Place, Headington, Oxford, UK OX3 9BX. E-mail: [email protected]

The authors have no conflicts of interest to declare.

留言 (0)

沒有登入
gif